GEODIS, a global logistics provider, has achieved World Health Organization (WHO) Good Distribution Practices (GDP) certification for its operations across Asia Pacific (APAC). This regional achievement demonstrates GEODIS’ ability to apply consistent, rigorous quality standards to the storage, handling and distribution of pharmaceutical products across multiple markets.
GDP sets internationally recognized requirements for maintaining the quality, safety and integrity of pharmaceutical products throughout the supply chain. The certification confirms that GEODIS has implemented robust quality management systems and controlled operational procedures across its certified APAC operations. The scope covers freight forwarding services for pharmaceuticals, healthcare products and medical devices, together with temperature-controlled storage at 2-8°C and 15-25°C, according to the activities performed at each location. It encompasses the critical safeguards required for healthcare logistics: temperature management, complete documentation, end-to-end traceability, risk assessment, trained personnel and stringent quality control. By aligning these practices within a common regional framework, GEODIS helps customers reduce distribution risk and maintain product integrity from origin to destination.
“Growing our pharmaceutical business is a strategic priority for GEODIS in Asia Pacific,” said Eric Martin-Neuville, GEODIS Regional President and CEO, Asia Pacific. “Healthcare customers operate in an environment where product integrity, regulatory compliance and supply chain reliability are non-negotiable. Regional GDP certification provides them with a consistent quality framework across our APAC operations and reinforces our ability to manage sensitive healthcare products with the control, visibility and discipline they require.”
This regional certification builds on GEODIS’ wider investment in healthcare logistics and quality excellence. The company’s global network includes 28 CEIV Pharma-certified (Center of Excellence for Independent Validators in Pharmaceutical Logistics) sites across the Americas, Asia Pacific, the Middle East and Europe.